Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 86 Results

Intervention Indication Therapeutic Area Year Actions
Momelotinib for the treatment of symptomatic and anaemic myelofibrosis Momelotinib Anaemic myelofibrosis Haematological Cancer and Lymphomas , Haematology 2022 View  |  Download
Natalizumab biosimilar for treating relapsing-remitting multiple sclerosis Natalizumab (BG00002; Tysabri; Antegren; AN-100226; ELND-002) Multiple sclerosis (MS) Neurology 2022 View  |  Download
Navitoclax with ruxolitinib for myelofibrosis Navitoclax (ABT 263, ABT-263) , Ruxolitinib (Jakavi; INCB018424; CTP-543; ruxolitinib phosphate) Myelofibrosis Haematological Cancer and Lymphomas 2022 View  |  Download
Nicardipine for treating aneurysmal subarachnoid haemorrhage Nicardipine (NicaPlant; nicardipine hydrochloride) Aneurysmal subarachnoid haemorrhage Cardiovascular System 2022 View  |  Download
Nivolumab in combination with chemotherapy for previously untreated unresectable or metastatic urothelial cancer Chemotherapy , Nivolumab (Opdivo; BMS-936558; ONO-4538) Urothelial cancer Urological Cancer 2022 View  |  Download
Odevixibat for cholestatic liver disease in Alagille syndrome patients Odevixibat (A4250) Alagille syndrome Genetic Disorders 2022 View  |  Download
Olaparib maintenance therapy for non-gBRCA mutated high-grade serous ovarian cancer after platinum-based chemotherapy Olaparib (Lynparza; MK-7339; AZD2281; AZD-2281) Non-gBRCA mutated high-grade serous ovarian cancer Female Reproductive Cancer 2022 View  |  Download
Oxybutynin hydrochloride for treating neurogenic detrusor overactivity Oxybutynin hydrochloride (Vesoxx) Neurogenic detrusor overactivity Neurology , Urology 2022 View  |  Download
Pembrolizumab and chemotherapy for resectable nonsmall-cell lung cancer Pembrolizumab (Keytruda; MK-3475) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2022 View  |  Download
Pembrolizumab with chemoradiotherapy for treating high-risk locally advanced cervical cancer Chemoradiotherapy , Pembrolizumab (Keytruda; MK-3475) Cervical cancer Female Reproductive Cancer 2022 View  |  Download
1 2 4 5 6 7 8 9
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications